Nandrolone
Pharmacology detail: animal ratings
These ratios are not measured human benefit or safety rankings.
Nandrolone is the ingredient associated with Deca. Begin with the ingredient and family, then compare its evidence and risks with testosterone.
Technical catalog description
Nandrolone is a 19-nortestosterone derivative that has been a cornerstone of bodybuilding for decades, particularly valued for its ability to promote steady, quality muscle gains with relatively mild side effects.
The compound is highly anabolic with reduced androgenic activity compared to Testosterone, making it more tolerable for many users. Nandrolone is renowned for its positive effects on joint health and collagen synthesis, often providing relief from joint pain that can accompany intense training.
Read next
Mechanism details
Nandrolone aromatizes to estrogen at roughly 20% the rate of Testosterone. That description does not establish a comparative dose calculation or a validated testosterone-and-nandrolone regimen.
The 19-nor chemistry, missing the carbon at position 19, also changes how the compound behaves at androgen-sensitive tissues. Testosterone converts via 5AR to DHT, which is aggressively androgenic at hair follicles and the prostate. Nandrolone converts via the same enzyme to dihydronandrolone, which is actually a weaker androgen than nandrolone itself. Nandrolone can reduce hair and prostate risk relative to testosterone because the converted metabolite is less potent, not just comparatively mild. It also explains why Finasteride and Dutasteride make things worse on nandrolone cycles. Blocking 5AR removes the dihydronandrolone conversion and leaves nandrolone as the primary androgen at those tissues, which is stronger than dihydronandrolone. Using a 5AR inhibitor on a nandrolone cycle is not protective.
The progestogenic activity is separate from the aromatization picture and is the source of nandrolone-specific problems. Nandrolone binds progesterone receptors with meaningful affinity, elevating prolactin independent of estrogen. Elevated prolactin produces the cluster of symptoms called “deca dick”: reduced libido, erectile dysfunction, and nipple sensitivity that looks identical to estrogen-driven gynecomastia. Many users chase this with aromatase inhibitors, which do nothing for prolactin. The correct tools are dopamine agonists: Cabergoline or bromocriptine, because prolactin is regulated through dopaminergic signaling, not through aromatase.
Sexual-function problems do not establish a testosterone-to-nandrolone dose ratio. This profile does not validate a ratio that prevents those symptoms.
Joint effects: nandrolone increases collagen synthesis and synovial fluid production. This is measurable. Competitive powerlifters and strength athletes frequently run nandrolone for the joint benefit specifically, not for additional mass, because being able to train heavier under load without joint pain limiting sessions has a real downstream effect on training output over months. The important caveat is that nandrolone provides pain modulation, not structural repair. Damaged cartilage does not regenerate. Users training through injuries that need rest are extending those injuries while feeling no warning signal to indicate it.
Detection time: nandrolone metabolites, specifically 19-norandrosterone, can be detected in urine for up to 18 months with modern WADA testing. Not 18 weeks. 18 months. This is the longest detection window of any widely used anabolic compound. Any athlete subject to anti-doping control should treat nandrolone as permanently detectable for practical planning purposes.
Decanoate versus NPP: These ester formulations have different kinetic profiles. No injection frequency, washout interval, or PCT start time is validated here.
Natural suppression with reduced fertility and testicular output
High estradiol, water retention, and gynecomastia risk if estrogen is unmanaged
Sexual dysfunction, low libido, or nipple sensitivity if prolactin rises
Water retention, erectile issues, and a slower recovery of natural testosterone
CBC / hematocrit
blood pressure
lipid panel
estradiol
prolactin
Uncontrolled hypertension or untreated cardiovascular disease
Pre-existing severe infertility concerns unless that risk is accepted and managed
Current uncontrolled estrogen-sensitive issues such as active gynecomastia
History of severe prolactin issues, sexual dysfunction, or intolerance to 19-nor compounds
Community descriptions of stacking do not validate combined amounts or predict total estrogenic effects.
Strength athletes discuss nandrolone for joint comfort. Those accounts do not establish a cycle length for maintaining training or producing a benefit.
No cycle duration, post-cycle medication schedule, or recovery timetable is established in this catalog.
Unverified community-use description: NPP is discussed as having a faster feedback loop than decanoate. These accounts do not establish a clearance interval or a treatment-adjustment schedule.
Starting PCT from a fixed number of weeks after an injection. This profile does not establish a washout interval or recovery regimen.
Using symptoms or an informal dose ratio to choose another medication. This catalog does not validate a ratio-based treatment recommendation.
Compared with Testosterone, nandrolone is discussed as having a different estrogenic profile. No weekly amount is validated here as providing a favorable tradeoff.
Compared with Trenbolone, nandrolone is a mass and recovery compound. Trenbolone used in a slight deficit adds muscle while reducing fat. Nandrolone in a caloric surplus adds mass with joint protection. The compounds are not interchangeable, and stacking both is uncommon because both are 19-nor compounds with overlapping prolactin implications, compounding that management problem.
Compared with Equipoise, nandrolone gives more joint benefit and more obvious mass production. EQ carries no prolactin risk and is hormonally simpler. For users who want the long steady growth pattern without the sexual function management overhead, EQ is the common alternative, accepting less joint benefit and somewhat less raw mass in exchange for simpler cycle management.